Who is sponsoring NCT05166681?

NCT05166681 is sponsored by Abouqir General Hospital.

What drugs are being tested in NCT05166681?

Interventions in NCT05166681: surgical wound suturing.

What condition does NCT05166681 study?

NCT05166681 studies Surgical Wound Closure Technique.

Is NCT05166681 still recruiting?

NCT05166681 is currently completed. Last updated 11 January 2022.

Last reviewed 2022-01-11 · How we verify

NCT05166681

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Aesthetic Surgical Wound Closure by a Single Layer in Comparison With Traditional Multi-layer Closure

Completed Phase 3 Last updated 11 January 2022

What this trial tests

Phase 3 trial testing surgical wound suturing in Surgical Wound Closure Technique in 200 participants. Completed in 5 December 2021.

Timeline

1 September 2020

Primary endpoint
5 December 2021

5 December 2021

Quick facts

Lead sponsor	Abouqir General Hospital
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	200
Start date	1 September 2020
Primary completion	5 December 2021
Estimated completion	5 December 2021
Sites	1 location across Egypt

Drugs / interventions tested

surgical wound suturing

Conditions studied

Surgical Wound Closure Technique — all drugs for Surgical Wound Closure Technique →

Sponsor

Abouqir General Hospital

Who can join

Adults 16 to 60, any sex, with Surgical Wound Closure Technique. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the study is comparing the results of aesthetic surgery wound closure by a single layer versus the traditional multi-layer closure as regards the wound healing time, local wound complications, and the scar formed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Abouqir General Hospital trials

Trials by the same sponsor.

NCT05190809 — Immediate Breast Reconstruction With Hybrid Fat Transfer · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05166681 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abouqir General Hospital
Last refreshed: 11 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05166681.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing